In vitro models for human malaria: targeting the liver stage

Area of Science:

• Malariology
• Parasitology
• Drug Discovery

Background:

• The Plasmodium liver stage is a key therapeutic target for preventing malaria, but current drugs often fail to address it.
• Existing liver-stage antimalarials pose risks for individuals with glucose-6-phosphate dehydrogenase deficiency.
• Developing effective in vitro models for studying human Plasmodium liver stages is a significant challenge.

Purpose of the Study:

• To review the evolution of in vitro liver models for human Plasmodium parasites.
• To discuss essential assay requirements for evaluating liver-stage antimalarial drug candidates.
• To provide recommendations for enhancing these models to accelerate preclinical therapeutic discovery.

Main Methods:

• Literature review of in vitro Plasmodium liver models.
• Analysis of assay requirements for drug screening.
• Synthesis of recommendations for model improvement.

Main Results:

• Overview of various in vitro liver models developed for Plasmodium.
• Identification of critical assay parameters for efficacy and safety testing.
• Proposed strategies to optimize current models for better drug discovery.

Conclusions:

• Improved in vitro liver models are essential for advancing antimalarial drug development.
• Addressing limitations in current models will facilitate the discovery of novel therapeutics.
• Future research should focus on refining models to better mimic human infection for targeted therapies.